Status:
UNKNOWN
Discovering Patterns in the Gut Microbiota Associated With the Risk of Stroke and the Outcome After a Stroke and Integration of These Data With Genomic Information to Find New Drug Targets and New Treatments to Improve Neurological Evolution and Functional Status of Stroke Patients.
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The composition of the intestinal microbiota is associated with the risk of stroke and with post-stroke neurological evolution. At the same time, the genetics and epigenetics of each patient are assoc...
Eligibility Criteria
Inclusion
- Patients with ischemic stroke (demonstrated by resonance or head CT).
Exclusion
- Patients under 18 years of age.
- Additional serious illness or unstable medical condition.
- Inclusion in clinical trials with neuroprotective drugs.
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04795687
Start Date
July 15 2020
End Date
December 31 2022
Last Update
September 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Recerca Hospital de la Santa Creu i Sant Pau
Barcelona, Spain, 08025